Gentolex’s story can be traced back to the summer of 2013, a group of young people with a vision in the industry to create opportunities connecting the world with better services and products guarantee.
major
products
Chemicals Products
Chemicals Products
An overall factory construction area of 250,000 square meters under international standard to offer flexible, scalable and cost-effective solutions.
Pharmaceutical Ingredients
Pharmaceutical Ingredients
Gentolex offers an extensive range of APIs and intermediates for development study and commercial application with cGMP standard from long-term collaborations. Documents and Certificates are supported to customers worldwide.
CRO&CDMO
CRO&CDMO
We have rich experience of offering CRO and CDMO services throughout the peptide drug development process for IND, NDA & ANDA projects, provide safe and efficient guidance from development to commercial production.
Procurement Service
Procurement Service
For those clients who prefer to avoid the complexity of dealing with multiple points of contact, we provide extra customized procurement services with the most superior and comprehensive supply chain sources.
about
Gentolex
Gentolex’s story can be traced back to the summer of 2013, a group of young people with a vision in the industry to create opportunities connecting the world with better services and products guarantee. Up to date, with years of accumulation, Gentolex Group has been serving customers from more than 15 countries across 5 continents, specially, representative teams are established in Mexico and South Africa, soon, more representative teams will be established for business services.
news and information
What should I do if I don’t lose weight after using GLP-1 drugs?
What to do if you don’t lose weight on a GLP-1 medication? Importantly, patience is essential when taking a GLP-1 medication like semaglutide. Ideally, it takes at least 12 weeks to see results. However, if you don’t see weight loss by then or have concerns, here are some options to consider. Tal...
Tirzepatide: The guardian of cardiovascular health
Cardiovascular disease is one of the leading global health threats, and the emergence of Tirzepatide brings new hope for the prevention and treatment of cardiovascular conditions. This medication works by activating both GIP and GLP-1 receptors, not only effectively cont...
Insulin Injection
Insulin, commonly known as the “diabetes injection”, exists in everyone’s body. Diabetics do not have enough insulin and need additional insulin, so they need to receive injections. Although it is a type of medicine, if it is injected properly and in the right amount, the “...
Semaglutide is not just for weight loss
Semaglutide is a glucose-lowering drug developed by Novo Nordisk for the treatment of type 2 diabetes. In June 2021, the FDA approved Semaglutide for marketing as a weight loss drug (trade name Wegovy). The drug is a glucagon-like peptide 1 (GLP-1) receptor agonist that can mimic its effects, red...
What is Mounjaro(Tirzepatide)?
Mounjaro(Tirzepatide) is a drug for weight loss and maintenance that contains the active substance tirzepatide. Tirzepatide is a long-acting dual GIP and GLP-1 receptor agonist. Both receptors are found in pancreatic alpha and beta endocrine cells, heart, blood vessels, ...